Beacon Pointe Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-17,565
| Closed | -$5.77M | – | 1194 |
|
|
2024
Q4 | $5.77M | Sell |
17,565
-234
| -1% | -$76.9K | 0.06% | 252 |
|
|
2024
Q3 | $5.96M | Sell |
17,799
-218
| -1% | -$72.9K | 0.07% | 250 |
|
|
2024
Q2 | $4.92M | Sell |
18,017
-964
| -5% | -$263K | 0.06% | 280 |
|
|
2024
Q1 | $6.56M | Buy |
+18,981
| New | +$6.56M | 0.07% | 241 |
|
|
2023
Q2 | – | Sell |
-881
| Closed | -$422K | – | 1079 |
|
|
2023
Q1 | $422K | Buy |
881
+185
| +27% | +$88.6K | 0.01% | 816 |
|
|
2022
Q4 | $293K | Buy |
+696
| New | +$293K | 0.01% | 870 |
|
|
2022
Q2 | – | Sell |
-3,307
| Closed | -$1.86M | – | 1054 |
|
|
2022
Q1 | $1.86M | Buy |
3,307
+2,960
| +853% | +$1.67M | 0.03% | 463 |
|
|
2021
Q4 | $262K | Buy |
347
+77
| +29% | +$58.1K | 0.01% | 780 |
|
|
2021
Q3 | $201K | Sell |
270
-233
| -46% | -$173K | 0.01% | 859 |
|
|
2021
Q2 | $324K | Buy |
+503
| New | +$324K | 0.01% | 640 |
|